Articles
3 June 2009
Vol. 1 No. 9: 3rd International Conference on Thrombosis and Hemostasis Issues in Cancer, Bergamo, October 14-16, 2005

Tissue factor-bearing microparticles and cancer-associated thrombosis

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
215
Views
0
Downloads

Authors

Microparticles were first described in normal blood as platelet dust.1 Sims carefully studied the generation of platelet microparticles during platelet activation by complement.2 These platelet microparticles bind to Factor Va and support prothrombinase activity3 as well as bind to Factor VIII.4 Since these reports, hundreds of studies have monitored microparticles, primarily using flow cytometry and light scattering, and correlated microparticle antigen expression within diverse groups of diseases. However, microparticles have been subjected to limited chemical analysis, including their lipid and protein content.

Altmetrics

Downloads

Citations

Supporting Agencies

How to Cite



Tissue factor-bearing microparticles and cancer-associated thrombosis. (2009). Hematology Meeting Reports (formerly Haematologica Reports), 1(9). https://doi.org/10.4081/hmr.v1i9.311